Review



recombinant human st3gal1  (Bio-Techne corporation)


Bioz Verified Symbol Bio-Techne corporation is a verified supplier
Bioz Manufacturer Symbol Bio-Techne corporation manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Bio-Techne corporation recombinant human st3gal1
    Recombinant Human St3gal1, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 94/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+st3gal1/Recombinant+Human+ST3GAL1+Protein%2C+CF/pm31897478-101-6-32
    Average 94 stars, based on 4 article reviews
    recombinant human st3gal1 - by Bioz Stars, 2026-09
    94/100 stars

    Images

    Related Articles

    Recombinant:

    Article Title: Differential distribution of N- and O-Glycans and variable expression of sialyl-T antigen on HeLa cells-Revealed by direct fluorescent glycan imaging.
    Article Snippet: Cells are covered with glycans.. The expression and distribution of specific glycans on the surface of a cell are important for various cellular functions.. Imaging these glycans is essential to aid elucidation of their biological roles.

    Article Title: Differential Expression of N- and O-glycans on HeLa Cells-Revealed by Direct Fluorescent Glycan Labeling with Recombinant Sialyltransferases
    Article Snippet: .. CMP-Azido-Sialic acid, UDP-Azido-GlcNAc, Biotinylated Alkyne, DAPI, recombinant human ST3Gal1, ST3Gal2, ST3Gal4, ST6Gal1, ST6GalNAc1, ST6GalNAc4, OGT and C. perfringens Neuraminidase were from Bio-Techne. .. Alkyne-Alexa Fluor® 488, alkyne-Alexa Fluor®555, streptavidin-Alexa ® Fluor 555 were from Thermo Fisher Scientific.



    Similar Products

    94
    Bio-Techne corporation recombinant human st3gal1
    Recombinant Human St3gal1, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+st3gal1/Recombinant+Human+ST3GAL1+Protein%2C+CF/pm31897478-101-6-32
    Average 94 stars, based on 1 article reviews
    recombinant human st3gal1 - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    93
    R&D Systems recombinant human st3gal1
    a Fc-pST3Gal1 (PS1) has four structural motifs. Amino acids shown in cyan (Q108A, Y233A, and Y269F) and magenta (H302A) were mutated in Dead and H302A mutants, respectively. b pST3Gal1 co-crystalized with CMP and Galβ1,3GalNAcα- p NP (PDB: 2WNB). Protein is in green, with selected residues and ligands shown as sticks. CMP is orange, Galβ1,3GalNAcα- p NP is yellow, amino acids mutated in Dead mutant are cyan, and H302A is magenta. c Western blots of Fc-fusion proteins expressed using HEK293T cells under reducing and non-reducing conditions. Detection was performed using anti-human Fc specific IgG. d LC-MS/MS analysis of <t>ST3Gal1</t> enzymatic activity. Recombinant hST3Gal1 served as positive control. H302A and dead mutants did not yield product (N = 1). e Lectin binding to HEK293T (gray bars), COLO357-FG (green bars) or Calu-3 (blue bars) cells, with or without sialidase treatment, measured using flow cytometry. Cells were incubated with 5 μg/mL fluorescent MALII, PNA, or 1 μg/mL purified Fc-fusion proteins pre-complexed with AF647-conjugated anti-human Fc specific IgG. Data are mean ± STD (N = 3 biological replicates). * p < 0.05 with respect to all other samples; ‡ p < 0.05 with respect to all other samples except samples marked by ‡ are not different from each other. P values calculated using one-way ANOVA followed by Tukey post-test. f Dose dependent binding of PS1 and H302A pre-complexed with AF488-conjugated anti-human Fc specific IgG. HEK293T cells treated with or without sialidase were used. Data are mean (N = 2 biological replicates). Source data including exact P values. Created in BioRender. Neelamegham, S. ( https://BioRender.com/tigz92o ).
    Recombinant Human St3gal1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+st3gal1/Recombinant+Human+ST3GAL1+Protein%2C+CF/pmc12274613-319-0-35
    Average 93 stars, based on 1 article reviews
    recombinant human st3gal1 - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    93
    R&D Systems recombinant human sialyltransferases
    a Fc-pST3Gal1 (PS1) has four structural motifs. Amino acids shown in cyan (Q108A, Y233A, and Y269F) and magenta (H302A) were mutated in Dead and H302A mutants, respectively. b pST3Gal1 co-crystalized with CMP and Galβ1,3GalNAcα- p NP (PDB: 2WNB). Protein is in green, with selected residues and ligands shown as sticks. CMP is orange, Galβ1,3GalNAcα- p NP is yellow, amino acids mutated in Dead mutant are cyan, and H302A is magenta. c Western blots of Fc-fusion proteins expressed using HEK293T cells under reducing and non-reducing conditions. Detection was performed using anti-human Fc specific IgG. d LC-MS/MS analysis of <t>ST3Gal1</t> enzymatic activity. Recombinant hST3Gal1 served as positive control. H302A and dead mutants did not yield product (N = 1). e Lectin binding to HEK293T (gray bars), COLO357-FG (green bars) or Calu-3 (blue bars) cells, with or without sialidase treatment, measured using flow cytometry. Cells were incubated with 5 μg/mL fluorescent MALII, PNA, or 1 μg/mL purified Fc-fusion proteins pre-complexed with AF647-conjugated anti-human Fc specific IgG. Data are mean ± STD (N = 3 biological replicates). * p < 0.05 with respect to all other samples; ‡ p < 0.05 with respect to all other samples except samples marked by ‡ are not different from each other. P values calculated using one-way ANOVA followed by Tukey post-test. f Dose dependent binding of PS1 and H302A pre-complexed with AF488-conjugated anti-human Fc specific IgG. HEK293T cells treated with or without sialidase were used. Data are mean (N = 2 biological replicates). Source data including exact P values. Created in BioRender. Neelamegham, S. ( https://BioRender.com/tigz92o ).
    Recombinant Human Sialyltransferases, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+st3gal1/Recombinant+Human+ST3GAL1+Protein%2C+CF/pm39470683-128-0-49
    Average 93 stars, based on 1 article reviews
    recombinant human sialyltransferases - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    90
    Glyco Expression Technologies human recombinant st3gal1
    a Fc-pST3Gal1 (PS1) has four structural motifs. Amino acids shown in cyan (Q108A, Y233A, and Y269F) and magenta (H302A) were mutated in Dead and H302A mutants, respectively. b pST3Gal1 co-crystalized with CMP and Galβ1,3GalNAcα- p NP (PDB: 2WNB). Protein is in green, with selected residues and ligands shown as sticks. CMP is orange, Galβ1,3GalNAcα- p NP is yellow, amino acids mutated in Dead mutant are cyan, and H302A is magenta. c Western blots of Fc-fusion proteins expressed using HEK293T cells under reducing and non-reducing conditions. Detection was performed using anti-human Fc specific IgG. d LC-MS/MS analysis of <t>ST3Gal1</t> enzymatic activity. Recombinant hST3Gal1 served as positive control. H302A and dead mutants did not yield product (N = 1). e Lectin binding to HEK293T (gray bars), COLO357-FG (green bars) or Calu-3 (blue bars) cells, with or without sialidase treatment, measured using flow cytometry. Cells were incubated with 5 μg/mL fluorescent MALII, PNA, or 1 μg/mL purified Fc-fusion proteins pre-complexed with AF647-conjugated anti-human Fc specific IgG. Data are mean ± STD (N = 3 biological replicates). * p < 0.05 with respect to all other samples; ‡ p < 0.05 with respect to all other samples except samples marked by ‡ are not different from each other. P values calculated using one-way ANOVA followed by Tukey post-test. f Dose dependent binding of PS1 and H302A pre-complexed with AF488-conjugated anti-human Fc specific IgG. HEK293T cells treated with or without sialidase were used. Data are mean (N = 2 biological replicates). Source data including exact P values. Created in BioRender. Neelamegham, S. ( https://BioRender.com/tigz92o ).
    Human Recombinant St3gal1, supplied by Glyco Expression Technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+st3gal1/human+recombinant+st3gal1/pmc11861894-341-17-6
    Average 90 stars, based on 1 article reviews
    human recombinant st3gal1 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    94
    R&D Systems st3gal1
    a Fc-pST3Gal1 (PS1) has four structural motifs. Amino acids shown in cyan (Q108A, Y233A, and Y269F) and magenta (H302A) were mutated in Dead and H302A mutants, respectively. b pST3Gal1 co-crystalized with CMP and Galβ1,3GalNAcα- p NP (PDB: 2WNB). Protein is in green, with selected residues and ligands shown as sticks. CMP is orange, Galβ1,3GalNAcα- p NP is yellow, amino acids mutated in Dead mutant are cyan, and H302A is magenta. c Western blots of Fc-fusion proteins expressed using HEK293T cells under reducing and non-reducing conditions. Detection was performed using anti-human Fc specific IgG. d LC-MS/MS analysis of <t>ST3Gal1</t> enzymatic activity. Recombinant hST3Gal1 served as positive control. H302A and dead mutants did not yield product (N = 1). e Lectin binding to HEK293T (gray bars), COLO357-FG (green bars) or Calu-3 (blue bars) cells, with or without sialidase treatment, measured using flow cytometry. Cells were incubated with 5 μg/mL fluorescent MALII, PNA, or 1 μg/mL purified Fc-fusion proteins pre-complexed with AF647-conjugated anti-human Fc specific IgG. Data are mean ± STD (N = 3 biological replicates). * p < 0.05 with respect to all other samples; ‡ p < 0.05 with respect to all other samples except samples marked by ‡ are not different from each other. P values calculated using one-way ANOVA followed by Tukey post-test. f Dose dependent binding of PS1 and H302A pre-complexed with AF488-conjugated anti-human Fc specific IgG. HEK293T cells treated with or without sialidase were used. Data are mean (N = 2 biological replicates). Source data including exact P values. Created in BioRender. Neelamegham, S. ( https://BioRender.com/tigz92o ).
    St3gal1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+st3gal1/Recombinant+Human+ST3GAL1+Protein%2C+CF/pm38673867-235-6-11
    Average 94 stars, based on 1 article reviews
    st3gal1 - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    Image Search Results


    a Fc-pST3Gal1 (PS1) has four structural motifs. Amino acids shown in cyan (Q108A, Y233A, and Y269F) and magenta (H302A) were mutated in Dead and H302A mutants, respectively. b pST3Gal1 co-crystalized with CMP and Galβ1,3GalNAcα- p NP (PDB: 2WNB). Protein is in green, with selected residues and ligands shown as sticks. CMP is orange, Galβ1,3GalNAcα- p NP is yellow, amino acids mutated in Dead mutant are cyan, and H302A is magenta. c Western blots of Fc-fusion proteins expressed using HEK293T cells under reducing and non-reducing conditions. Detection was performed using anti-human Fc specific IgG. d LC-MS/MS analysis of ST3Gal1 enzymatic activity. Recombinant hST3Gal1 served as positive control. H302A and dead mutants did not yield product (N = 1). e Lectin binding to HEK293T (gray bars), COLO357-FG (green bars) or Calu-3 (blue bars) cells, with or without sialidase treatment, measured using flow cytometry. Cells were incubated with 5 μg/mL fluorescent MALII, PNA, or 1 μg/mL purified Fc-fusion proteins pre-complexed with AF647-conjugated anti-human Fc specific IgG. Data are mean ± STD (N = 3 biological replicates). * p < 0.05 with respect to all other samples; ‡ p < 0.05 with respect to all other samples except samples marked by ‡ are not different from each other. P values calculated using one-way ANOVA followed by Tukey post-test. f Dose dependent binding of PS1 and H302A pre-complexed with AF488-conjugated anti-human Fc specific IgG. HEK293T cells treated with or without sialidase were used. Data are mean (N = 2 biological replicates). Source data including exact P values. Created in BioRender. Neelamegham, S. ( https://BioRender.com/tigz92o ).

    Journal: Nature Communications

    Article Title: Engineering glycosyltransferases into glycan binding proteins using a mammalian surface display platform

    doi: 10.1038/s41467-025-62018-z

    Figure Lengend Snippet: a Fc-pST3Gal1 (PS1) has four structural motifs. Amino acids shown in cyan (Q108A, Y233A, and Y269F) and magenta (H302A) were mutated in Dead and H302A mutants, respectively. b pST3Gal1 co-crystalized with CMP and Galβ1,3GalNAcα- p NP (PDB: 2WNB). Protein is in green, with selected residues and ligands shown as sticks. CMP is orange, Galβ1,3GalNAcα- p NP is yellow, amino acids mutated in Dead mutant are cyan, and H302A is magenta. c Western blots of Fc-fusion proteins expressed using HEK293T cells under reducing and non-reducing conditions. Detection was performed using anti-human Fc specific IgG. d LC-MS/MS analysis of ST3Gal1 enzymatic activity. Recombinant hST3Gal1 served as positive control. H302A and dead mutants did not yield product (N = 1). e Lectin binding to HEK293T (gray bars), COLO357-FG (green bars) or Calu-3 (blue bars) cells, with or without sialidase treatment, measured using flow cytometry. Cells were incubated with 5 μg/mL fluorescent MALII, PNA, or 1 μg/mL purified Fc-fusion proteins pre-complexed with AF647-conjugated anti-human Fc specific IgG. Data are mean ± STD (N = 3 biological replicates). * p < 0.05 with respect to all other samples; ‡ p < 0.05 with respect to all other samples except samples marked by ‡ are not different from each other. P values calculated using one-way ANOVA followed by Tukey post-test. f Dose dependent binding of PS1 and H302A pre-complexed with AF488-conjugated anti-human Fc specific IgG. HEK293T cells treated with or without sialidase were used. Data are mean (N = 2 biological replicates). Source data including exact P values. Created in BioRender. Neelamegham, S. ( https://BioRender.com/tigz92o ).

    Article Snippet: Recombinant human ST3Gal1 (rhST3Gal1, Product code: 6905-GT-020), Recombinant human P-selectin Fc chimera (P-selectin-Fc, Product code: 137-PS-050), sheep anti-hGCNT1 IgG (Product code: AF7248-SP) and HRP donkey anti-sheep H + L IgG (Product code: HAF016) were from R&D Systems (Minneapolis, MN).

    Techniques: Mutagenesis, Western Blot, Liquid Chromatography with Mass Spectroscopy, Activity Assay, Recombinant, Positive Control, Binding Assay, Flow Cytometry, Incubation, Purification

    a Isogenic HEK293T KO cells lacking selected glycan-processing enzymes or transporters were produced. b Next-generation sequencing (NGS) results for isogenic clones lacking GCNT1 , SLC35A1 , and ST3Gal1 . Wildtype DNA and amino acid sequence corresponding to sense strand are shown above, with gene edited sequence below. Exons and introns appear in uppercase and lowercase, respectively. As two sgRNA were added simultaneously to create KOs, red and green represent the first and second editing regions, and blue presents the protospacer adjacent motif (PAM) on sense ( GCNT1 and ST3Gal1 KO) or anti-sense strands ( SLC35A1 KO). The entire sequence between the sgRNA cut sites was excised in the GCNT1 and SLC35A1 KO. This resulted in a few different closely-resembling read sequences. The frequency of occurrence of each of these edit patterns is shown on the right side of the DNA sequence (underlined). c Flow cytometry binding assay using 5 μg/mL fluorescent lectins (MALII and PNA for O -glycans, PHA-L and ECL for N -glycans). HEK293T WT cells and panel of isogenic HEK293T KO cells were used. d Flow cytometry binding assay using 1 μg/mL purified Fc-fusion proteins pre-complexed with AF488-conjugated anti-human Fc specific IgG. Data are mean ± STD (N = 6 for ( c , d ), except N = 5 for PHA-L and ECL, biological replicates). P values calculated using one-way ANOVA followed by the Tukey post-test. Data show that H302A binds sialylated core-2 O -linked glycans. * p < 0.05 with respect to all other samples; ‡ p < 0.05 with respect to all other samples except that samples marked by ‡ are not different from each other; † p < 0.05 with respect to WT cells. Source data are provided in file. Created in BioRender. Neelamegham, S. ( https://BioRender.com/tigz92o .

    Journal: Nature Communications

    Article Title: Engineering glycosyltransferases into glycan binding proteins using a mammalian surface display platform

    doi: 10.1038/s41467-025-62018-z

    Figure Lengend Snippet: a Isogenic HEK293T KO cells lacking selected glycan-processing enzymes or transporters were produced. b Next-generation sequencing (NGS) results for isogenic clones lacking GCNT1 , SLC35A1 , and ST3Gal1 . Wildtype DNA and amino acid sequence corresponding to sense strand are shown above, with gene edited sequence below. Exons and introns appear in uppercase and lowercase, respectively. As two sgRNA were added simultaneously to create KOs, red and green represent the first and second editing regions, and blue presents the protospacer adjacent motif (PAM) on sense ( GCNT1 and ST3Gal1 KO) or anti-sense strands ( SLC35A1 KO). The entire sequence between the sgRNA cut sites was excised in the GCNT1 and SLC35A1 KO. This resulted in a few different closely-resembling read sequences. The frequency of occurrence of each of these edit patterns is shown on the right side of the DNA sequence (underlined). c Flow cytometry binding assay using 5 μg/mL fluorescent lectins (MALII and PNA for O -glycans, PHA-L and ECL for N -glycans). HEK293T WT cells and panel of isogenic HEK293T KO cells were used. d Flow cytometry binding assay using 1 μg/mL purified Fc-fusion proteins pre-complexed with AF488-conjugated anti-human Fc specific IgG. Data are mean ± STD (N = 6 for ( c , d ), except N = 5 for PHA-L and ECL, biological replicates). P values calculated using one-way ANOVA followed by the Tukey post-test. Data show that H302A binds sialylated core-2 O -linked glycans. * p < 0.05 with respect to all other samples; ‡ p < 0.05 with respect to all other samples except that samples marked by ‡ are not different from each other; † p < 0.05 with respect to WT cells. Source data are provided in file. Created in BioRender. Neelamegham, S. ( https://BioRender.com/tigz92o .

    Article Snippet: Recombinant human ST3Gal1 (rhST3Gal1, Product code: 6905-GT-020), Recombinant human P-selectin Fc chimera (P-selectin-Fc, Product code: 137-PS-050), sheep anti-hGCNT1 IgG (Product code: AF7248-SP) and HRP donkey anti-sheep H + L IgG (Product code: HAF016) were from R&D Systems (Minneapolis, MN).

    Techniques: Glycoproteomics, Produced, Next-Generation Sequencing, Clone Assay, Sequencing, Flow Cytometry, Binding Assay, Purification